Enveric Biosciences ENVB
NASDAQ ENVB
$1.43 +0.04 (+2.86%)
As of: Aug 21, 2026 · 1:23 PM EDT

Enveric Biosciences (ENVB) Net Margin Growth (5y) (2019 - 2020)

Enveric Biosciences (ENVB) Net Margin Growth (5y) (2019 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.49 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.24 Bn 78.25 Bn 3.93 Bn
3 Argenx Se 65.26 Bn 60.08 Bn 1.37 Bn
4 Moderna 58.83 Bn 53.69 Bn 52.00 Mn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn
7 BioNTech SE 27.95 Bn 9.56 Bn 668.28 Mn
8 Insmed 27.50 Bn 26.34 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.44 Bn -
10 Enveric Biosciences 5.70 Mn -2.59 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 -703.00
Jun 30, 2020 -2,037.00
Mar 31, 2020 -4,483.00
Jun 30, 2019 -1,238.00